Secretory phospholipase (sPLA
BCSCs
BCSCs differentiation
EGFR signaling
Epithelial to mesenchymal transition (EMT)
Tumorigenic potential
sPLA(2)-IIA
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
15 10 2023
15 10 2023
Historique:
received:
17
07
2023
revised:
21
07
2023
accepted:
26
07
2023
medline:
4
9
2023
pubmed:
11
8
2023
entrez:
11
8
2023
Statut:
ppublish
Résumé
Breast cancer is the second most cancer worldwide in females. The primary factor responsible for tumor recurrence is the presence of breast cancer stem cells (BCSCs), which escape the chemo-radiotherapy. In this study, we have investigated the role of Secretory phospholipase-A2 Group 2A (sPLA
Identifiants
pubmed: 37566923
pii: S0006-291X(23)00929-4
doi: 10.1016/j.bbrc.2023.07.057
pii:
doi:
Substances chimiques
Phospholipases A2, Secretory
EC 3.1.1.4
Phospholipases
EC 3.1.-
Group II Phospholipases A2
EC 3.1.1.4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
98-104Informations de copyright
Copyright © 2023. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.